XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.23.2

Supplemental Balance Sheet Information | 6 Months Ended
--- | ---
Jun. 30, 2023
Supplemental Balance Sheet Information [Abstract] |
SUPPLEMENTAL BALANCE SHEET INFORMATION | NOTE F – SUPPLEMENTAL BALANCE SHEET INFORMATION Components of selected captions within our accompanying unaudited consolidated balance sheets are as follows: Trade accounts receivable, net
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Trade accounts receivable | $ | 2,261 |  |  | $ | 2,079 |
Allowance for credit losses | (127) |  |  | (109) |
| $ | 2,134 |  |  | $ | 1,970 |
The following is a roll forward of our Allowance for credit losses:
| Three Months Ended June 30, |  | Six Months Ended June 30,
(in millions) | 2023 |  | 2022 |  | 2023 |  | 2022
Beginning balance | $ | 118 |  |  | $ | 113 |  |  | $ | 109 |  |  | $ | 108 |
Credit loss expense | 19 |  |  | 9 |  |  | 35 |  |  | 20 |
Write-offs | (10) |  |  | (5) |  |  | (16) |  |  | (11) |
Ending balance | $ | 127 |  |  | $ | 117 |  |  | $ | 127 |  |  | $ | 117 |
In accordance with FASB ASC Topic 326, Financial Instruments - Credit Losses (FASB ASC Topic 326), we record credit loss reserves to Allowance for credit losses when we establish Trade accounts receivable if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach, applying country or region-specific factors, to determine the reserve to record at accounts receivable commencement for certain customers. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account. We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic and geopolitical conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other entities, and, in southern Europe, relative to those in other countries. In addition, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have more limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends. Inventories
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Finished goods | $ | 1,372 |  |  | $ | 1,171 |
Work-in-process | 175 |  |  | 147 |
Raw materials | 703 |  |  | 548 |
| $ | 2,250 |  |  | $ | 1,867 |
Other current assets
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Restricted cash and restricted cash equivalents | $ | 135 |  |  | $ | 149 |
Derivative assets | 234 |  |  | 232 |
Licensing arrangements | 53 |  |  | 60 |
Other | 353 |  |  | 290 |
| $ | 773 |  |  | $ | 731 |
Property, plant and equipment, net
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Land | $ | 141 |  |  | $ | 137 |
Buildings and improvements | 1,790 |  |  | 1,695 |
Equipment, furniture and fixtures | 3,427 |  |  | 3,297 |
Capital in progress | 604 |  |  | 598 |
| 5,962 |  |  | 5,728 |
Less: accumulated depreciation | 3,428 |  |  | 3,282 |
| $ | 2,534 |  |  | $ | 2,446 |
Depreciation expense was $88 million for the second quarter of 2023, $80 million for the second quarter of 2022, $170 million for the first six months of 2023 and $156 million for the first six months of 2022. Other long-term assets
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Restricted cash equivalents | $ | 60 |  |  | $ | 48 |
Operating lease right-of-use assets | 445 |  |  | 386 |
Derivative assets | 156 |  |  | 149 |
Investments | 422 |  |  | 407 |
Licensing arrangements | 49 |  |  | 67 |
Indemnification asset | 168 |  |  | 172 |
Other | 295 |  |  | 271 |
| $ | 1,595 |  |  | $ | 1,500 |
Accrued expenses
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Legal reserves | $ | 209 |  |  | $ | 231 |
Payroll and related liabilities | 843 |  |  | 830 |
Rebates | 363 |  |  | 352 |
Contingent consideration | 97 |  |  | 74 |
Other | 653 |  |  | 674 |
| $ | 2,164 |  |  | $ | 2,160 |
Other current liabilities
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Deferred revenue | $ | 242 |  |  | $ | 220 |
Licensing arrangements | 55 |  |  | 79 |
Taxes payable | 400 |  |  | 232 |
Other | 242 |  |  | 230 |
| $ | 940 |  |  | $ | 761 |
Other long-term liabilities
| As of
(in millions) | June 30, 2023 |  | December 31, 2022
Accrued income taxes | $ | 489 |  |  | $ | 597 |
Legal reserves | 210 |  |  | 212 |
Contingent consideration | 10 |  |  | 75 |
Licensing arrangements | 60 |  |  | 80 |
Operating lease liabilities | 401 |  |  | 347 |
Deferred revenue | 295 |  |  | 289 |
Other | 460 |  |  | 434 |
| $ | 1,926 |  |  | $ | 2,035 |

X
- Definition Supplemental Balance Sheet Information. + References No definition available. + Details
Name: | bsx_SupplementalBalanceSheetInformationAbstract
Namespace Prefix: | bsx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration